Lv2
130 积分 2024-05-15 加入
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy
9小时前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors
10天前
已完结
Systemic Kras ablation disrupts myeloid cell homeostasis in adult mice
1个月前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors
2个月前
已完结
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
2个月前
已完结
Novel Small-Molecule miR-124 Inducer Acts as "a Physiological Brake" of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis
2个月前
已完结
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy
2个月前
已完结
Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
2个月前
已完结
BRAF inhibitors in Melanoma: Structural Insights, Therapeutic Resistance, and Biological Evaluation of Quinazoline Derivatives
2个月前
已关闭
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies
3个月前
已完结
皖公网安备34019202002308
